Genmab A/S (GMAB) stock
GMABNasdaqPharmaceutical PreparationsAlso trades as GNMSF
Financials through fiscal 2025, year ended Dec 31, 2025Score 0/30
$51.37−0.37 (-0.72%)
Close on Nov 13, 2026
Genmab A/S statistics
25 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Dec 31, 2025
- Share price as of
- –
Share statisticsIndustry
- Shares Change (YoY)
- -3.04%
- –
- Float
- 129M
- –
- Shares Held by Insiders
- 0.00%
- –
- Shares Held by Institutions
- 79.5%
- –
Short sellingIndustry
- Short Interest
- 10M
- –
- Short Interest Change
- 46.4%
- –
- Days to Cover
- 1.24
- –
Stock price statisticsIndustry
- Price Change (1 Week)
- -4.21%
- –
- Price Change (1 Month)
- 35.8%
- –
- Price Change (3 Months)
- 56.4%
- –
- Price Change (6 Months)
- 93.6%
- –
- Price Change (YTD)
- 66.8%
- –
- Price Change (1 Year)
- 68.6%
- –
- Price Change (3 Years)
- 58.6%
- –
- Price Change (5 Years)
- 18.1%
- –
- Price Change (10 Years)
- 192.4%
- –
- Average Volume (10 Days)
- 5M
- –
- Average Volume (20 Days)
- 7M
- –
- Average Volume (90 Days)
- 4M
- –
- Relative Volume
- 1.02
- –
- Relative Strength Index (14)
- 59.1
- –
- Volatility (1 Year)
- 45.8%
- –
- Beta (5 Years)
- 0.73
- –
EfficiencyIndustry
- Employee Count
- 3,029
- –
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | GMAB | S&P 500 | Difference | GMAB per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +40.5% | -3.0% | +43.5 pts | ||
| 3 months | +63.9% | -2.8% | +66.7 pts | ||
| Year to date | +66.8% | +11.5% | +55.3 pts | ||
| 1 year | +69.9% | +13.5% | +56.4 pts | ||
| 3 years | +59.8% | +77.7% | −17.9 pts | +16.9% | +21.1% |
| 5 years | +18.1% | +72.6% | −54.5 pts | +3.4% | +11.5% |
| 10 years | +192.4% | +308.2% | −115.7 pts | +11.3% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
10M GMAB shares were sold short on Oct 30, 2026, up 46.4% from the previous report. At recent volumes it would take 1.2 days to buy them back. Over the last 20 sessions, 49.3% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 9,659,086 | +46.4% | 7,815,853 | 1.2 |
| Oct 15, 2026 | 6,598,711 | +8.9% | 4,930,979 | 1.3 |
| Sep 30, 2026 | 6,062,007 | +23.2% | 2,894,650 | 2.1 |
| Sep 15, 2026 | 4,920,530 | -28.0% | 1,554,592 | 3.2 |
| Aug 31, 2026 | 6,830,174 | -10.1% | 2,804,775 | 2.4 |
| Aug 14, 2026 | 7,598,057 | +2.8% | 2,786,953 | 2.7 |
| Jul 31, 2026 | 7,387,972 | -2.3% | 1,600,289 | 4.6 |
| Jul 15, 2026 | 7,558,770 | -9.3% | 2,388,669 | 3.2 |
| Jun 30, 2026 | 8,329,932 | -3.0% | 1,775,467 | 4.7 |
| Jun 15, 2026 | 8,588,992 | -14.5% | 1,473,241 | 5.8 |
| May 29, 2026 | 10,048,894 | -1.1% | 2,202,451 | 4.6 |
| May 15, 2026 | 10,160,510 | +19.6% | 2,087,104 | 4.9 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?